시장보고서

상품코드

1493355

미국의 유세포분석 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

U.S. Flow Cytometry Market Size, Share & Trends Analysis Report By Product (Software, Accessories), By Technology (Cell-based, Bead-based), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 05월 | 리서치사:

Grand View Research | 페이지 정보: 영문 70 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국의 유세포분석 시장 성장과 동향 :

Grand View Research, Inc의 최신 리포트에 따르면 미국의 유세포분석 시장 규모는 2030년까지 26억 1,000만 달러에 달할 것으로 예측되며, 2024-2030년의 CAGR은 6.8%로 성장하고 있습니다.

유세포 분석 시장은 암 환자 및 기타 만성질환 증가로 인해 미국에서 빠르게 성장하고 있습니다. 미국암협회(ACS)에 따르면 2019년 미국에서 15세에서 39세 사이의 청소년 및 젊은 성인 암 사망자 수는 약 9270명이었으며, 2020년에는 약 8만9500명의 암 환자가 새로 진단되었습니다. 이러한 요인들이 시장 성장의 원동력이 될 것으로 보입니다.

COVID-19 팬데믹은 시장에 긍정적인 영향을 미쳤습니다. 예를 들어 2020년 8월 Springer지에 발표된 연구에 따르면 말초혈액 단핵구(PBMC) 표현형 유세포 분석이 COVID-19의 임상 진행 위험을 예측하는 데 도움이 되며, 항원 제시의 개선과 더 효과적인 적응 면역 반응이 COVID-19 회복과 관련이 있는 것으로 나타났습니다. COVID-19를 필두로 감염성 질환과 만성질환의 발생 빈도가 증가함에 따라 연구 및 진단을 위한 기술에 대한 수요가 증가하고 있으며, 이는 시장 성장을 촉진하고 있습니다.

또한 미국은 탄탄한 의료 인프라를 보유하고 있으며, 막대한 의료비가 투입되고, 첨단 유세포 분석 기술이 널리 사용되고 있습니다. 또한 연구 대학이 광범위한 조사 활동에 참여하고 제약 회사도 발전하고 있으므로 연구 목적의 유세포 분석 워크플로우에 대한 수요가 매우 높습니다. 이는 미국이 의료에 많은 투자를 하고, 의료 인프라가 고도로 발달하고, 최첨단 유세포 분석 기술이 널리 사용되고 있기 때문입니다.

미국 유세포 분석법 시장 보고서 하이라이트

제품별로는 유세포 분석기기가 2023년 35.08%의 점유율을 차지하며 시장을 주도할 것입니다. 유세포 분석 장비는 HIV/AIDS 진행 모니터링, 백혈병의 미세 잔존 병변 검출, 면역 세포 기능 평가 등 임상 진단에 매우 중요하며, 이는 이 분야의 성장을 가속할 것입니다.
기술 측면에서 2023년 시장 점유율은 세포 기반 부문이 지배적이었습니다. 이 기술은 세포의 크기, 복잡성, 특정 분자의 존재와 같은 특징을 기반으로 세포를 분석합니다. 반면, 비드 기반 부문은 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
용도별로 보면 임상 부문이 2023년 가장 큰 시장 점유율을 차지했습니다. 산업 부문은 예측 기간 중 가장 빠르게 성장할 것으로 예상됩니다.
최종 용도별로는 학술기관 부문이 2023년 가장 큰 시장 점유율을 차지했습니다. 임상 실험실은 예측 기간 중 가장 빠르게 성장할 것으로 예상됩니다.
미국은 암, HIV 등 질병 발병률이 급증하고 있으며, 미국 유세포 분석 시장 수요가 급증하고 있습니다.
2024년 1월, 소니 바이오테크놀러지는 다용도 유세포 분석기 EC800을 출시했습니다. 이 혁신적인 기기는 입자 크기 측정, 면역형질화, 세포 생존율, 절대 세포 수, 세포 사멸 검출 등 다양한 용도를 지원하며, EC800은 다양한 연구 및 진단 요구에 적합한 비용 효율적인 솔루션을 제공합니다.

주요 시장 참여 기업에 의한 최근 동향과 영향 분석
기업/경쟁 분류
벤더 구도
기업 개요
- Sysmex Corp
- Becton, Dickinson, and Company(BD)
- Danaher Corp
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Sony Biotechnology, Inc.
- Beckman Coulter, Inc.
- Cytek Biosciences
- BioLegend, Inc.
- Enzo Biochem Inc.
- Cell Signaling Technology, Inc.
- NeoGenomics Laboratories
- Q2 Solutions(IQVIA)
- Elabscience Biotechnology Inc.
- Stratedigm, Inc.
- BioLegend, Inc.
- Union Biometrica, Inc.
- BennuBio Inc.
- ORLFO Technologies

KSA 24.06.20

U.S. Flow Cytometry Market Growth & Trends:

The U.S. flow cytometry market size is anticipated to reach USD 2.61 billion by 2030 and is growing at a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market for flow cytometry is expanding faster in the U.S. owing to increased cancer cases and other chronic illnesses. According to the American Cancer Society (ACS), there were roughly 9,270 cancer deaths among adolescents and young adults in the U.S. in 2019 who were between the ages of 15 and 39, and there were about 89,500 new cases of cancer diagnosed in 2020. These factors would drive market growth.

The COVID-19 pandemic had a positive effect on the market. For instance, in August 2020, research published in Springer discovered that flow cytometry analysis of peripheral blood mononuclear cell (PBMC) phenotype helped to predict the risk of COVID-19 clinical progression and indicated that improved antigen presentation and more effective adaptive immune responses are associated with recovery from COVID-19. The increasing frequency of infectious and chronic disorders, most notably the COVID-19 outbreak, has increased the need for technology for study and diagnosis, supporting the market's growth.

Furthermore, the U.S. has a robust healthcare infrastructure, significant healthcare spending, and widespread usage of highly advanced flow cytometry technologies. In addition, owing to research universities engaging in a wide range of research activities and having developed pharmaceutical enterprises, there is an enormous need for flow cytometry workflow for research purposes. This results from the U.S.'s substantial investment in healthcare, highly developed healthcare infrastructure, and widespread usage of cutting-edge flow cytometry technology.

U.S. Flow Cytometry Market Report Highlights:

Based on product, instrument dominated the market and accounted for 35.08% in 2023. Flow cytometry instruments are crucial in clinical diagnostics for applications such as immunophenotyping cells to monitor HIV/AIDS progression, detect minimal residual disease in leukemia, and assess immune cell function, which will fuel the segment growth
In terms of technology, the cell-based segment dominated the market share in 2023. This technology involves analyzing cells based on their characteristics, such as size, complexity, and the presence of specific molecules. On the other hand, the bead-based segment is expected to grow at the fastest CAGR over the forecast period
Based on application, the clinical segment held the largest market share in 2023. The industrial segment is expected to grow fastest over the forecast period
In terms of end-use, the academic institute segment held the largest market share in 2023. Clinical testing labsare anticipated to witness the fastest growth over the forecast period
The U.S. is the major dominating country in the market due to the surging incidence rate of diseases such as cancer and HIV amongst the population in this country, which is boosting the demand for U.S. flow cytometry market
In January 2024, Sony Biotechnology launched the EC800, a highly versatile flow cytometry analyzer. This innovative device caters to various applications, such as particle sizing, immunophenotyping, cell viability, absolute cell counting, and apoptosis detection, among others. The EC800 offers cost-effective solutions suitable for diverse research and diagnostic needs.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Application
- 1.2.4. End-use
- 1.2.5. Region
- 1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Technology Outlook
- 2.2.3. Application Outlook
- 2.2.4. End-use Outlook
- 2.2.5. Regional Outlook
2.3. Competitive Insights

Chapter 3. U.S. Flow Cytometry Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. U.S. Flow Cytometry Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. U.S. Flow Cytometry Market: Product Estimates & Trend Analysis

4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Flow Cytometry Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 4.4.1. Instruments
  - 4.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 4.4.1.2. Cell Analyzers
  - 4.4.1.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 4.4.1.3. Cell Sorters
  - 4.4.1.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 4.4.2. Reagents & Consumables
  - 4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 4.4.3. Software
  - 4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 4.4.4. Accessories
  - 4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 4.4.5. Services
  - 4.4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. U.S. Flow Cytometry Market: Technology Estimates & Trend Analysis

5.1. Technology Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Flow Cytometry Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 5.4.1. Cell-based
  - 5.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 5.4.2. Bead-based
  - 5.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. U.S. Flow Cytometry Market: Application Estimates & Trend Analysis

6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Flow Cytometry Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 6.4.1. Research
  - 6.4.1.1. Market estimates and forecasts 2018 - 2030 (USD million)
  - 6.4.1.2. Pharmaceutical
  - 6.4.1.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.1.2.2. Drug Discovery
  - 6.4.1.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.1.2.3. In Vitro Toxicity
  - 6.4.1.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.1.2.4. Stem Cell
  - 6.4.1.2.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.1.3. Apoptosis
  - 6.4.1.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.1.4. Cell Sorting
  - 6.4.1.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.1.5. Cell Cycle Analysis
  - 6.4.1.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.1.6. Immunology
  - 6.4.1.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.1.7. Cell Viability
  - 6.4.1.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 6.4.2. Industrial
  - 6.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 6.4.3. Clinical
  - 6.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.3.2. Cancer
  - 6.4.3.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.3.3. Organ Transplantation
  - 6.4.3.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.3.4. Immunodeficiency
  - 6.4.3.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.3.5. Hematology
  - 6.4.3.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 6.4.3.6. Autoimmune Disorders
  - 6.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Flow Cytometry Market: End-use Estimates & Trend Analysis

7.1. End-use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. U.S. Flow Cytometry Market by End-use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 7.4.1. Clinical Testing Labs
  - 7.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 7.4.2. Academic Institutes
  - 7.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 7.4.3. Commercial Organizations
  - 7.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 7.4.3.2. Biotechnology Companies
  - 7.4.3.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 7.4.3.3. Pharmaceutical Companies
  - 7.4.3.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 7.4.3.4. CROs
  - 7.4.3.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 7.4.4. Hospitals
  - 7.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. U.S. Flow Cytometry Market: Region Estimates & Trend Analysis

8.1. Regional Market Share, 2023 & 2030
8.2. U.S. Flow Cytometry Market by Regional Outlook
8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 8.3.1. West
  - 8.3.1.1. Market estimates and forecasts 2018 - 2030 (USD million)
- 8.3.2. Midwest
  - 8.3.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 8.3.3. Northeast
  - 8.3.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 8.3.4. Southwest
  - 8.3.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 8.3.5. Southeast
  - 8.3.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company heat map analysis, 2023
9.4. Company Profiles
- 9.4.1. Sysmex Corp
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Becton, Dickinson, and Company (B.D.)
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Danaher Corp
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. Thermo Fisher Scientific, Inc.
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. Agilent Technologies, Inc.
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. Bio-Rad Laboratories, Inc.
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. Sony Biotechnology, Inc.
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. Beckman Coulter, Inc.
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. Cytek Biosciences
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. BioLegend, Inc.
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Product benchmarking
  - 9.4.10.4. Strategic initiatives
- 9.4.11. Enzo Biochem Inc.
  - 9.4.11.1. Company overview
  - 9.4.11.2. Financial performance
  - 9.4.11.3. Product benchmarking
  - 9.4.11.4. Strategic initiatives
- 9.4.12. Cell Signaling Technology, Inc.
  - 9.4.12.1. Company overview
  - 9.4.12.2. Financial performance
  - 9.4.12.3. Product benchmarking
  - 9.4.12.4. Strategic initiatives
- 9.4.13. NeoGenomics Laboratories
  - 9.4.13.1. Company overview
  - 9.4.13.2. Financial performance
  - 9.4.13.3. Product benchmarking
  - 9.4.13.4. Strategic initiatives
- 9.4.14. Q2 Solutions (IQVIA)
  - 9.4.14.1. Company overview
  - 9.4.14.2. Financial performance
  - 9.4.14.3. Product benchmarking
  - 9.4.14.4. Strategic initiatives
- 9.4.15. Elabscience Biotechnology Inc.
  - 9.4.15.1. Company overview
  - 9.4.15.2. Financial performance
  - 9.4.15.3. Product benchmarking
  - 9.4.15.4. Strategic initiatives
- 9.4.16. Stratedigm, Inc.
  - 9.4.16.1. Company overview
  - 9.4.16.2. Financial performance
  - 9.4.16.3. Product benchmarking
  - 9.4.16.4. Strategic initiatives
- 9.4.17. BioLegend, Inc.
  - 9.4.17.1. Company overview
  - 9.4.17.2. Financial performance
  - 9.4.17.3. Product benchmarking
  - 9.4.17.4. Strategic initiatives
- 9.4.18. Union Biometrica, Inc.
  - 9.4.18.1. Company overview
  - 9.4.18.2. Financial performance
  - 9.4.18.3. Product benchmarking
  - 9.4.18.4. Strategic initiatives
- 9.4.19. BennuBio Inc.
  - 9.4.19.1. Company overview
  - 9.4.19.2. Financial performance
  - 9.4.19.3. Product benchmarking
  - 9.4.19.4. Strategic initiatives
- 9.4.20. ORLFO Technologies
  - 9.4.20.1. Company overview
  - 9.4.20.2. Financial performance
  - 9.4.20.3. Product benchmarking
  - 9.4.20.4. Strategic initiativesw

미국의 유세포분석 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

U.S. Flow Cytometry Market Size, Share & Trends Analysis Report By Product (Software, Accessories), By Technology (Cell-based, Bead-based), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

미국의 유세포분석 시장 성장과 동향 :

미국 유세포 분석법 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 미국의 유세포분석 시장 변수, 동향, 범위

제4장 미국의 유세포분석 시장 : 제품 추정·동향 분석

제5장 미국의 유세포분석 시장 : 기술 추정·동향 분석

제6장 미국의 유세포분석 시장 : 용도 추정·동향 분석

제7장 미국의 유세포분석 시장 : 최종 용도 추정·동향 분석

제8장 미국의 유세포분석 시장 : 지역 추정·동향 분석

제9장 경쟁 구도